Clinical Trial Update: Doxazosin an a1 Antagonist for Alcohol Dependence [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial of doxazosin, an alpha-1 adrenergic antagonist, for alcohol use disorder (with anxiety) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders

Drugs mentioned

• Doxazosin (doxazosin)

Snippet

Sponsor: Brown University | Conditions: Alcohol Dependence, Anxiety | EARLY_Phase 1 | Status: COMPLETED